Sami Corwin

Stock Analyst at William Blair

(0.10)
# 4,411
Out of 5,044 analysts
11
Total ratings
16.67%
Success rate
-20.73%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sami Corwin

Kyverna Therapeutics
Aug 20, 2025
Initiates: Outperform
Price Target: n/a
Current: $7.61
Upside: -
Sarepta Therapeutics
Jun 20, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $24.22
Upside: -
Ultragenyx Pharmaceutical
May 28, 2025
Initiates: Outperform
Price Target: $65
Current: $34.77
Upside: +86.94%
Nkarta
May 15, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $2.31
Upside: -
Applied Therapeutics
Dec 23, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.30
Upside: -
Tenaya Therapeutics
Jun 10, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.56
Upside: -
Neurogene
Mar 21, 2024
Initiates: Outperform
Price Target: n/a
Current: $30.96
Upside: -
Mesoblast
Aug 4, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $16.73
Upside: -
CRISPR Therapeutics AG
May 30, 2023
Reinstates: Outperform
Price Target: $75
Current: $64.17
Upside: +16.88%
Legend Biotech
May 25, 2023
Initiates: Market Perform
Price Target: n/a
Current: $32.57
Upside: -
Initiates: Outperform
Price Target: $66
Current: $70.00
Upside: -5.71%